Unknown

Dataset Information

0

Coronavirus Disease 2019: Coronaviruses and Blood Safety.


ABSTRACT: With the outbreak of unknown pneumonia in Wuhan, China, in December 2019, a new coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), aroused the attention of the entire world. The current outbreak of infections with SARS-CoV-2 is termed Coronavirus Disease 2019 (COVID-19). The World Health Organization declared COVID-19 in China as a Public Health Emergency of International Concern. Two other coronavirus infections-SARS in 2002-2003 and Middle East Respiratory Syndrome (MERS) in 2012-both caused severe respiratory syndrome in humans. All 3 of these emerging infectious diseases leading to a global spread are caused by ?-coronaviruses. Although coronaviruses usually infect the upper or lower respiratory tract, viral shedding in plasma or serum is common. Therefore, there is still a theoretical risk of transmission of coronaviruses through the transfusion of labile blood products. Because more and more asymptomatic infections are being found among COVID-19 cases, considerations of blood safety and coronaviruses have arisen especially in endemic areas. In this review, we detail current evidence and understanding of the transmission of SARS-CoV, MERS-CoV, and SARS-CoV-2 through blood products as of February 10, 2020, and also discuss pathogen inactivation methods on coronaviruses.

PROVIDER: S-EPMC7135848 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC7164679 | BioStudies
| S-EPMC7836940 | BioStudies
| S-EPMC7212949 | BioStudies
| S-EPMC7260568 | BioStudies
| S-EPMC8189044 | BioStudies
| S-EPMC7264107 | BioStudies
| S-EPMC7844200 | BioStudies
| S-EPMC7180238 | BioStudies
| S-EPMC7228394 | BioStudies
| S-EPMC7574915 | BioStudies